Literature DB >> 19885137

Continuous glucose profiles in healthy subjects under everyday life conditions and after different meals.

Guido Freckmann1, Sven Hagenlocher, Annette Baumstark, Nina Jendrike, Ralph C Gillen, Katja Rössner, Cornelia Haug.   

Abstract

BACKGROUND: This study investigated continuous glucose profiles in nondiabetic subjects.
METHODS: Continuous interstitial glucose measurement was performed under everyday life conditions (2 days) and after ingestion of four meals with standardized carbohydrate content (50 grams), but with different types of carbohydrates and variable protein and fat content. Twenty-four healthy volunteers (12 female, 12 male, age 27.1 +/- 3.6 years) participated in the study. Each subject wore two microdialysis devices (SCGM1, Roche Diagnostics) simultaneously.
RESULTS: The mean 24-hour interstitial glucose concentration under everyday life conditions was 89.3 +/- 6.2 mg/dl (mean +/- SD, n = 21), and mean interstitial glucose concentrations at daytime and during the night were 93.0 +/- 7.0 and 81.8 +/- 6.3 mg/dl, respectively. The highest postprandial glucose concentrations were observed after breakfast: 132.3 +/- 16.7 mg/dl (range 101-168 mg/dl); peak concentrations after lunch and dinner were 118.2 +/- 13.4 and 123.0 +/- 16.9 mg/dl, respectively. Mean time to peak glucose concentration was between 46 and 50 minutes. After ingestion of standardized meals with fast absorption characteristics, peak interstitial glucose concentrations were 133.2 +/- 14.4 and 137.2 +/- 21.1 mg/dl, respectively. Meals with a higher fiber, protein, and fat content induced a smaller increase and a slower decrease of postprandial glucose concentrations with peak values of 99.2 +/- 10.5 and 122.1 +/- 20.4 mg/dl, respectively.
CONCLUSIONS: This study provided continuous glucose profiles in nondiabetic subjects and demonstrated that differences in meal composition are reflected in postprandial interstitial glucose concentrations. Regarding the increasing application of continuous glucose monitoring in diabetic patients, these data suggest that detailed information about the ingested meals is important for adequate interpretation of postprandial glucose profiles.

Entities:  

Keywords:  continuous glucose monitoring; continuous glucose profiles; healthy subjects; interstitial fluid glucose; postprandial glucose

Year:  2007        PMID: 19885137      PMCID: PMC2769652          DOI: 10.1177/193229680700100513

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  27 in total

1.  The SCGM1 System: subcutaneous continuous glucose monitoring based on microdialysis technique.

Authors:  Michael Schoemaker; Elisabeth Andreis; Josef Röper; Reinhard Kotulla; Volker Lodwig; Karin Obermaier; Peter Stephan; Wilhelm Reuschling; Malte Rutschmann; Ralf Schwaninger; Uwe Wittmann; Helmut Rinne; Heinz Kontschieder; Werner Strohmeier
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

Review 2.  Should postprandial glucose be measured and treated to a particular target? Yes.

Authors:  Jaime Davidson
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

3.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

Authors:  Satish Garg; Howard Zisser; Sherwyn Schwartz; Timothy Bailey; Roy Kaplan; Samuel Ellis; Lois Jovanovic
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

4.  Nocturnal differences in subcutaneous tissue glucose between forearm and abdominal sites during continuous glucose monitoring in normal subjects.

Authors:  A von Dobeln; U Adamson; P E Lins
Journal:  Diabetes Metab       Date:  2005-09       Impact factor: 6.041

5.  Detection of hypoglycaemia by microdialysis measurements of glucose in subcutaneous adipose tissue.

Authors:  E Moberg; E Hagström-Toft; J Bolinder
Journal:  Horm Metab Res       Date:  1997-09       Impact factor: 2.936

6.  Measurements of glucose control.

Authors:  F J Service; P C O'Brien; R A Rizza
Journal:  Diabetes Care       Date:  1987 Mar-Apr       Impact factor: 19.112

7.  Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system.

Authors:  Christoph Kapitza; Volker Lodwig; Karin Obermaier; Klaas Jan C Wientjes; Klaas Hoogenberg; Karsten Jungheim; Lutz Heinemann
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

8.  Postprandial plasma-glucose and -insulin responses to different complex carbohydrates.

Authors:  P A Crapo; G Reaven; J Olefsky
Journal:  Diabetes       Date:  1977-12       Impact factor: 9.461

9.  In vivo subcutaneous adipose tissue glucose kinetics after glucose ingestion in obesity and fasting.

Authors:  E Hagström; P Arner; P Engfeldt; S Rössner; J Bolinder
Journal:  Scand J Clin Lab Invest       Date:  1990-04       Impact factor: 1.713

10.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

View more
  42 in total

1.  Measurements of the thermal coefficient of optical attenuation at different depth regions of in vivo human skins using optical coherence tomography: a pilot study.

Authors:  Ya Su; X Steve Yao; Zhihong Li; Zhuo Meng; Tiegen Liu; Longzhi Wang
Journal:  Biomed Opt Express       Date:  2015-01-12       Impact factor: 3.732

2.  Effect of delay in transportation of extracellular glucose into cardiomyocytes under diabetic condition: a study through mathematical model.

Authors:  Phonindra Nath Das; Ajay Kumar; Nandadulal Bairagi; Samrat Chatterjee
Journal:  J Biol Phys       Date:  2020-06-25       Impact factor: 1.365

3.  Parameters affecting postprandial blood glucose: effects of blood glucose measurement errors.

Authors:  Theodor Koschinsky; Sascha Heckermann; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2008-01

4.  Synchronized stimulation and continuous insulin sensing in a microfluidic human Islet on a Chip designed for scalable manufacturing.

Authors:  Aaron L Glieberman; Benjamin D Pope; John F Zimmerman; Qihan Liu; John P Ferrier; Jennifer H R Kenty; Adrian M Schrell; Nikita Mukhitov; Kevin L Shores; Adrian Buganza Tepole; Douglas A Melton; Michael G Roper; Kevin Kit Parker
Journal:  Lab Chip       Date:  2019-09-10       Impact factor: 6.799

5.  Magnetic Optical Microarray Imager for Diagnosing Type of Diabetes in Clinical Blood Serum Samples.

Authors:  Vini Singh; Cassandra Rodenbaugh; Sadagopan Krishnan
Journal:  ACS Sens       Date:  2016-02-18       Impact factor: 7.711

Review 6.  Electrochemical and surface plasmon insulin assays on clinical samples.

Authors:  Vini Singh; Sadagopan Krishnan
Journal:  Analyst       Date:  2018-03-26       Impact factor: 4.616

7.  Choose right carbohydrates and right fats (RCRF) - keys to optimal health.

Authors:  Stig Bengmark
Journal:  Hepatobiliary Surg Nutr       Date:  2017-12       Impact factor: 7.293

8.  Short-wavelength optoacoustic spectroscopy based on water muting.

Authors:  Jaya Prakash; Mir Mehdi Seyedebrahimi; Ara Ghazaryan; Jaber Malekzadeh-Najafabadi; Vipul Gujrati; Vasilis Ntziachristos
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

9.  Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.

Authors:  Ashley Pinckney; Mark R Rigby; Lynette Keyes-Elstein; Carol L Soppe; Gerald T Nepom; Mario R Ehlers
Journal:  Clin Ther       Date:  2016-05-18       Impact factor: 3.393

Review 10.  Strategies for clinical trials in type 1 diabetes.

Authors:  Mario R Ehlers
Journal:  J Autoimmun       Date:  2016-04-05       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.